InfuSystem ‘makes advances,’ building on tech investments

ROCHESTER HILLS, Mich. - InfuSystem Holdings reported revenue of $36.2 million for the fourth quarter and $143.4 million for the full year ended Dec. 31, 2025, increases of 7% and 6%, respectively, compared to the prior year. Patient Services net revenue was $21.9 million for the quarter, and Device Solutions net revenue was $14.4 million for the quarter. For the full year, Patient Services revenue $86.5 million and Device Solutions was $86.9 million. "During the fourth quarter we continued to make advances on key initiatives that are expected to deliver on our clear mandate to execute with discipline, deliver profitable growth and drive long-term value creation for our shareholders," said Carrie LaChance, CEO. "We made significant progress on our new revenue cycle management platform, which is already lowering claims processing costs and improving billing efficiency, and on our enterprise technology upgrade, which is expected to go live at the end of the first quarter of 2026. We also established new relationships with home healthcare durable medical equipment ("DME") manufacturers. I’m confident that our focus and progress on these initiatives will help us build on the margin expansion and cash flow improvements we delivered in 2025." InfuSystem is providing annual net revenue guidance for the full year 2026 in two parts by providing the impact of the biomedical services contract restructuring, which will reduce our net revenues by $7.1 million, or 5.5%, separately from the pro-forma growth rate for the unaffected business. This pro-forma net revenue growth is estimated to be between 6% to 8% for 2026. The company is also forecasting adjusted EBITDA margin (non-GAAP) to be in the mid to low 20%s. This includes the planned reduction in the implementation expenses for the company's upgraded information technology systems, which are expected to go online at the end of the first quarter of 2026. The company intends to update its annual guidance throughout the year.